Suchergebnisse - "Joseph I. Clark"

1

Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report

von: Joseph I. Clark

2018, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
2

A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma

von: Joseph I. Clark

2018, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
3

Combination Trimodality Therapy Using Vismodegib for Basal Cell Carcinoma of the Face

von: Alec M. Block

2015, in: Case Reports in Oncological Medicine

Wird geladen...
4

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry

von: Brendan Curti

2017, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
5

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

von: Elizabeth I. Buchbinder

2019, in: Journal for ImmunoTherapy of Cancer

Wird geladen...
6

HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cells

von: Tamson V. Moore

2021, in: Molecular Therapy: Oncolytics

Wird geladen...
7

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0

von: Ryan J. Sullivan

2018, in: Journal for ImmunoTherapy of Cancer

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!